Awareness of and Willingness to Use Oral Pre-Exposure Prophylaxis for HIV Prevention among HIV-Serodiscordant Heterosexual Couples: A Cross-Sectional Survey in Xinjiang, China
Open Access
- 16 July 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (7), e67392
- https://doi.org/10.1371/journal.pone.0067392
Abstract
We aimed to investigate the awareness of and willingness to use oral pre-exposure prophylaxis (PrEP) for HIV prevention among HIV-negative partners in HIV-serodiscordant heterosexual couples in Xinjiang, China and determine factors that predict willingness to use oral PrEP. Between November 2009 and December 2010, a cross-sectional survey was carried out among 351 HIV-negative partners in HIV-serodiscordant heterosexual couples from three cities in Xinjiang, China. Participants completed a self-administered questionnaire to assess their awareness of and willingness to use oral PrEP. Additionally, blood samples were collected to test for HIV infection. Univariate and multivariate logistic regression analyses were performed to identify predictors of willingness to use oral PrEP. Only 10 participants (2.8%) reported having heard of PrEP, and only two reported ever using PrEP. However, 297 (84.6%) reported that they were willing to use oral PrEP if it was proven to be both safe and effective. Results of multivariate analysis revealed the following independent predictors of willingness to use oral PrEP: monthly household income (adjusted odds ratio = 2.78, <1000 RMB vs. ≥1000 RMB, 95% confidence interval: 1.36–5.69), perceived likelihood of contracting HIV from HIV-positive partner (adjusted odds ratio = 2.63, likely vs. unlikely, 95% confidence interval: 1.12–6.19), and worrying about being discriminated against by others due to oral PrEP use (adjusted odds ratio = 9.43, No vs. Yes, 95% confidence interval: 3.78–23.50). Our results showed HIV-negative partners in HIV-serodiscordant heterosexual couples in China had low awareness of oral PrEP but high willingness to use oral PrEP for HIV prevention. Cost of oral PrEP should be taken into consideration in future PrEP prevention strategy. In addition, efforts should be made to reduce stigma attached to oral PrEP use, which may increase its acceptability among potential users.This publication has 29 references indexed in Scilit:
- Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003–11): a national observational cohort studyThe Lancet, 2013
- Combination Prevention: New Hope for Stopping the EpidemicCurrent HIV/AIDS Reports, 2013
- Preexposure Prophylaxis for HIV Infection among African WomenThe New England Journal of Medicine, 2012
- Tenofovir-based pre-exposure prophylaxis for HIV preventionCurrent Opinion in Infectious Diseases, 2012
- HIV Prevention by Oral Preexposure ProphylaxisCold Spring Harbor Perspectives in Medicine, 2011
- Enrollment Characteristics and Risk Behaviors of Injection Drug Users Participating in the Bangkok Tenofovir Study, ThailandPLOS ONE, 2011
- Implications of HIV PrEP Trials ResultsAIDS Research and Human Retroviruses, 2011
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenThe New England Journal of Medicine, 2010
- Preexposure Prophylaxis and Predicted Condom Use Among High-Risk Men Who Have Sex With MenJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Preexposure Antiretroviral Prophylaxis Attitudes in High-Risk Boston Area Men Who Report Having Sex With Men: Limited Knowledge and Experience but Potential for Increased Utilization After EducationJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009